Celldex Therapeutics
CLDX
CLDX
184 hedge funds and large institutions have $1.99B invested in Celldex Therapeutics in 2025 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 57 increasing their positions, 60 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
3.34% more ownership
Funds ownership: 106.51% → 109.85% (+3.3%)
0% more funds holding
Funds holding: 184 → 184 (0)
5% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 60
Holders
184
Holding in Top 10
6
Calls
$2.29M
Puts
$750K
Top Buyers
| 1 | +$60M | |
| 2 | +$33.4M | |
| 3 | +$14.6M | |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$14.2M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$10.4M |
Top Sellers
| 1 | -$56.2M | |
| 2 | -$12.2M | |
| 3 | -$9.9M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$9.03M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$7.7M |
